FromtheDepartmentsof ‡ Biochemistry, § Pharmacology,and CellularandStructuralBiologyandtheBarshopCenter Forlongevityandagingstudies,universityoftexashealthsciencecenter,sanantonio, Texas 78229

Ramon A. Riojas,Chintan K. Kikani,Changhua Wang,Xuming Mao,Lijun Zhou,Paul R. Langlais,Derong Hu,James L. Roberts,Lily Dong,Feng Liu
2006-01-01
Abstract:3-Phosphoinositide-dependent protein kinase-1 (PDK1) mediates phosphorylation and activation of members of the AGC protein kinase family and plays an essential role in insulin signaling and action. However, whether and how PDK1 activity is regulated in cells remains largely uncharacterized. In the present study, we show that PDK1 undergoes insulin-stimulated and phosphatidylinositol 3-kinase-dependent phosphorylation at Ser 244 in the activation loop and at a novel site: Ser 163 in the hinge region between the two lobes of the kinase domain. Sequence alignment studies revealed that the residue corresponding to Ser 163 of PDK1 in all other AGC kinases is glutamate, suggesting that a negative charge at this site may be important for PDK1 function. Replacing Ser 163 with a negatively charged residue, glutamate, led to a 2-fold increase in PDK1 activity. Molecular modeling studies suggested that phosphorylated Ser 163 may form additional hydrogen bonds with Tyr 149 and Gln 223 . In support of this, mutation of Tyr 149 to Ala is sufficient to reduce PDK1 activity. Taken together, our results suggest that PDK1 phosphorylation of Ser 163 may provide a mechanism to fine-tune PDK1 activity and function in cells.
What problem does this paper attempt to address?